This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
1cda
From Proteopedia
(Difference between revisions)
m (Protected "1cda" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | + | ==A 3-DIMENSIONAL MODEL FOR THE CD40 LIGAND REVEALS A CLOSE SIMILARITY TO THE TUMOR NECROSIS FACTORS== | |
| + | <StructureSection load='1cda' size='340' side='right' caption='[[1cda]]' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1CDA FirstGlance]. <br> | ||
| + | </td></tr><tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1cda FirstGlance], [http://www.ebi.ac.uk/pdbsum/1cda PDBsum]</span></td></tr> | ||
| + | <table> | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Based on the similarity in primary structure between the newly characterized ligand for CD40 (CD40L) and the tumor necrosis factors (TNFs), we have modeled a detailed 3-D structure for CD40L. We used the known structure of TNF alpha as a template for the generation of the CD40L model. The soundness of the model-building algorithms was verified by constructing a 3-D model of TNF beta and comparing it to its crystallographically determined structure. The CD40L sequence is entirely compatible with the 'jelly-roll' beta-strand structure characteristic of the TNFs. Like the TNFs, CD40L is predicted to form a compact trimer, although the interactions between monomers are distinct from those found in the TNFs. The model predicts which regions of CD40L could interact with its receptor(s) and which amino acids are essential for the maintenance of its trimeric structure. | ||
| - | + | A 3-D model for the CD40 ligand predicts that it is a compact trimer similar to the tumor necrosis factors.,Peitsch MC, Jongeneel CV Int Immunol. 1993 Feb;5(2):233-8. PMID:8095800<ref>PMID:8095800</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | == | + | == References == |
| - | + | <references/> | |
| - | + | __TOC__ | |
| - | + | </StructureSection> | |
| - | + | ||
| - | < | + | |
[[Category: Jongeneel, C V]] | [[Category: Jongeneel, C V]] | ||
[[Category: Peitsch, M C]] | [[Category: Peitsch, M C]] | ||
Revision as of 16:57, 20 August 2014
A 3-DIMENSIONAL MODEL FOR THE CD40 LIGAND REVEALS A CLOSE SIMILARITY TO THE TUMOR NECROSIS FACTORS
| |||||||||||
